Bulgaria's Webit invests in France's InHeart

The financial injection reflects Webit's commitment to fostering game-changing technologies that redefine healthcare, the company said in a statement.

The investment was part of an $11 million funding round, led by Vesalius Biocapital IV and co-led by Elaia Partners, with additional backing from NACO, Sagana, Sofia Angel Ventures and CWR Funds, InHeart said in a separate statement.

InHeart, founded in 2017, has raised $12.2 million in total to grow its AI and advanced imaging platform for tailored cardiac procedures. The company offers an AI-driven digital twin of the heart, used by healthcare providers such as Mayo Clinic Hospital, Bordeaux Hospital, PENN Hospital, Northwell Hospital and John Hopkins.

"This new round allows us to go further in addressing the needs of cardiac patients from early screening and disease detection through advanced therapeutic support. It is exciting for us to be at the forefront of transforming the healthcare industry with the power of AI technology by improving the efficiency of care, quality of decision-making, and effectiveness and safety of medical interventions," InHeart chairman and CEO Todor Jeliaskov said.

As of 1157 CEST on Tuesday, shares in Webit Investment Network traded 2.74% higher at 0.75 levs ($0.41/0.38 euro) on the Bulgarian Stock Exchange.

($ = 0.928 euro)